1. Advance in the pharmacological and comorbidities management of heart failure with preserved ejection fraction: evidence from clinical trials

   • Wu Meifang
   • Wu Ying
   • Lin Liming

   ReviewPaper 10 August 2023 Pages: 305 - 320

2. Sex differences in transthyretin cardiac amyloidosis

   • Alberto Aimo
   • Giorgia Panichella
   • Silvia Maffei

   ReviewPaper Open access 11 August 2023 Pages: 321 - 330

   

3. Predictive biomarkers for the early detection and management of heart failure

   • Vignesh Mariappan
   • Rajesh Srinivasan
   • Agieshkumar Balakrishna Pillai

   ReviewPaper 13 September 2023 Pages: 331 - 353

   

4. The sympathetic nervous system in heart failure revisited

   • Filippos Triposkiadis
   • Alexandros Briasoulis
   • Andrew Xanthopoulos

   ReviewPaper 14 September 2023 Pages: 355 - 365

   

5. Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy

   • Frank L. Dini
   • Erberto Carluccio
   • on behalf of the Heart Failure Study Group of the Italian Society of Cardiology

   ReviewPaper 20 September 2023 Pages: 367 - 378

   

6. Assessment and management of heart failure in patients with chronic kidney disease

   • Andrea Igoren Guaricci
   • Francesca Sturdà
   • Francesco Pesce

   ReviewPaper Open access 20 September 2023 Pages: 379 - 394

   

7. Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy

   • Lutong Pu
   • Jialin Li
   • Yucheng Chen

   ReviewPaper 22 October 2023 Pages: 395 - 404

   

8. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis

   • Xiaoxiao Lin
   • Guomin Wu
   • Jinyu Huang

   ReviewPaper 23 October 2023 Pages: 405 - 416

   

9. Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction

   • Zixi Zhang
   • Yichao Xiao
   • Qiming Liu

   ReviewPaper Open access 08 November 2023 Pages: 417 - 430

   

10. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal

    • Annamaria Del Franco
    • Giulia Iannaccone
    • Iacopo Olivotto

    ReviewPaper 25 November 2023 Pages: 431 - 444

    

11. Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging

    • Francesco Santoro
    • Enrica Vitale
    • Natale Daniele Brunetti

    ReviewPaper 02 December 2023 Pages: 445 - 462

    

12. Can the hemodynamic model in heart failure be restored based on analysis of ventricular-arterial coupling?

    • Johannes Soma

    Letter 02 December 2023 Pages: 463 - 464

13. Echocardiographic manifestations in end-stage renal disease

    • Takahide Ito
    • Kanako Akamatsu

    ReviewPaper 10 December 2023 Pages: 465 - 478

    

14. A systematic review and meta-analysis of the efficacy and safety of Mavacamten therapy in international cohort of 524 patients with hypertrophic cardiomyopathy

    • Magdi S. Yacoub
    • Tamer El-Nakhal
    • Osama Soliman

    ReviewPaper 19 December 2023 Pages: 479 - 496

    

15. Takotsubo pathophysiology and complications: what we know and what we do not know

    • Mehdi Shadmand
    • Jacob Lautze
    • Ali Mehdirad MD

    ReviewPaper 27 December 2023 Pages: 497 - 510

    

16. Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy

    • Danni Wu
    • Wei Chen

    ReviewPaper Open access 18 January 2024 Pages: 511 - 521

    

17. Anti-bradycardia pacing—impact on patients with HFpEF: a systematic review

    • Alexandru Ababei
    • Luciana Andreea Hrib
    • Ștefan Bogdan

    ReviewPaper Open access 28 January 2024 Pages: 523 - 534

    

18. The role and application of current pharmacological management in patients with advanced heart failure

    • Alberto Palazzuoli
    • Gaetano Ruocco
    • Carl J. Lavie

    ReviewPaper 29 January 2024 Pages: 535 - 548

    

19. Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature

    • Taylor McKenzie
    • Genevieve M. Hale
    • Jasmine Wade

    ReviewPaper 01 February 2024 Pages: 549 - 558

    

20. Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective?

    • Carlotta Sciaccaluga
    • Maria Cristina Procopio
    • Serafina Valente

    ReviewPaper Open access 08 February 2024 Pages: 559 - 569

    

21. Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal

    • Annamaria Del Franco
    • Giulia Iannaccone
    • Iacopo Olivotto

    Correction 31 January 2024 Pages: 571 - 571